David Sancho-Cantus , Laura Cubero-Plazas , Jesús Privado , Eduardo Jesús Aguilar García-Iturrospe , Montserrat Cañabate Ros , Esther Navarro-Illana , José Enrique de la Rubia Ortí
{"title":"肌萎缩侧索硬化症患者 ALS 抑郁量表-12(ADI-12)的西班牙语改编和验证","authors":"David Sancho-Cantus , Laura Cubero-Plazas , Jesús Privado , Eduardo Jesús Aguilar García-Iturrospe , Montserrat Cañabate Ros , Esther Navarro-Illana , José Enrique de la Rubia Ortí","doi":"10.1016/j.arcmed.2023.102936","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p><span>Patients with Amyotrophic Lateral Sclerosis<span> (ALS) have a higher prevalence of mood disorders, including depression, than the general population. Non-specific measurement instruments have been used to evaluate depression in these patients, which complicates accurate diagnosis. The ALS Depression Inventory (ADI-12) exclusively assesses depressive symptoms </span></span>in patients with ALS.</p></div><div><h3>Aim</h3><p>To adapt and validate the ADI-12 in a Spanish sample.</p></div><div><h3>Methods</h3><p>A selective design was used with 74 patients with ALS, using the ADI-12 questionnaire. The original instrument was translated and back-translated into Spanish. The internal structure, temporal stability, convergent, and discriminant validity of the instrument were analyzed.</p></div><div><h3>Results</h3><p>Two confirmatory models showed internal validity (p = 0.502 for the one-factor model, p = 0.507 for the two-factor model). The Cronbach's alpha (0.900 in the first measurement and 0.889 in the second one) indicated a high internal consistency of the test. The Pearson correlation (0.90) indicated high temporal stability. In terms of convergent validity, the ADI-12 showed moderate correlations with the Beck Anxiety Inventory (BAI) (0.51–0.58), and low correlations with time since ALS diagnosis (–0.26 to –0.27).</p></div><div><h3>Limitations</h3><p>The main limitation of the present study was the small sample size.</p></div><div><h3>Conclusions</h3><p>The ADI-12 is fitted to a single general factor of depression, and the scale shows high internal consistency and high temporal stability, therefore, its use is recommended for the diagnosis of depression in patients with ALS.</p></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":null,"pages":null},"PeriodicalIF":4.7000,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Spanish adaptation and validation of the ALS Depression Inventory-12 (ADI-12) in patients with Amyotrophic Lateral Sclerosis\",\"authors\":\"David Sancho-Cantus , Laura Cubero-Plazas , Jesús Privado , Eduardo Jesús Aguilar García-Iturrospe , Montserrat Cañabate Ros , Esther Navarro-Illana , José Enrique de la Rubia Ortí\",\"doi\":\"10.1016/j.arcmed.2023.102936\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p><span>Patients with Amyotrophic Lateral Sclerosis<span> (ALS) have a higher prevalence of mood disorders, including depression, than the general population. Non-specific measurement instruments have been used to evaluate depression in these patients, which complicates accurate diagnosis. The ALS Depression Inventory (ADI-12) exclusively assesses depressive symptoms </span></span>in patients with ALS.</p></div><div><h3>Aim</h3><p>To adapt and validate the ADI-12 in a Spanish sample.</p></div><div><h3>Methods</h3><p>A selective design was used with 74 patients with ALS, using the ADI-12 questionnaire. The original instrument was translated and back-translated into Spanish. The internal structure, temporal stability, convergent, and discriminant validity of the instrument were analyzed.</p></div><div><h3>Results</h3><p>Two confirmatory models showed internal validity (p = 0.502 for the one-factor model, p = 0.507 for the two-factor model). The Cronbach's alpha (0.900 in the first measurement and 0.889 in the second one) indicated a high internal consistency of the test. The Pearson correlation (0.90) indicated high temporal stability. In terms of convergent validity, the ADI-12 showed moderate correlations with the Beck Anxiety Inventory (BAI) (0.51–0.58), and low correlations with time since ALS diagnosis (–0.26 to –0.27).</p></div><div><h3>Limitations</h3><p>The main limitation of the present study was the small sample size.</p></div><div><h3>Conclusions</h3><p>The ADI-12 is fitted to a single general factor of depression, and the scale shows high internal consistency and high temporal stability, therefore, its use is recommended for the diagnosis of depression in patients with ALS.</p></div>\",\"PeriodicalId\":8318,\"journal\":{\"name\":\"Archives of Medical Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2023-12-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Medical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0188440923001790\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Medical Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0188440923001790","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
摘要
背景肌萎缩侧索硬化症(ALS)患者的情绪障碍(包括抑郁症)发病率高于普通人群。评估这些患者抑郁情况的测量工具不具有特异性,这使得准确诊断变得更加复杂。ALS抑郁量表(ADI-12)专门评估ALS患者的抑郁症状。目的在西班牙样本中改编并验证ADI-12。方法对74名ALS患者采用选择性设计,使用ADI-12问卷。原始问卷被翻译成西班牙文并进行回译。结果两个确认模型显示了内部有效性(单因素模型 p = 0.502,双因素模型 p = 0.507)。Cronbach's alpha(第一次测量为 0.900,第二次测量为 0.889)表明测验具有较高的内部一致性。Pearson 相关性(0.90)表明测试具有较高的时间稳定性。在收敛效度方面,ADI-12 与贝克焦虑量表(BAI)呈中等相关性(0.51-0.58),与确诊 ALS 后的时间呈低相关性(-0.26--0.27)。
Spanish adaptation and validation of the ALS Depression Inventory-12 (ADI-12) in patients with Amyotrophic Lateral Sclerosis
Background
Patients with Amyotrophic Lateral Sclerosis (ALS) have a higher prevalence of mood disorders, including depression, than the general population. Non-specific measurement instruments have been used to evaluate depression in these patients, which complicates accurate diagnosis. The ALS Depression Inventory (ADI-12) exclusively assesses depressive symptoms in patients with ALS.
Aim
To adapt and validate the ADI-12 in a Spanish sample.
Methods
A selective design was used with 74 patients with ALS, using the ADI-12 questionnaire. The original instrument was translated and back-translated into Spanish. The internal structure, temporal stability, convergent, and discriminant validity of the instrument were analyzed.
Results
Two confirmatory models showed internal validity (p = 0.502 for the one-factor model, p = 0.507 for the two-factor model). The Cronbach's alpha (0.900 in the first measurement and 0.889 in the second one) indicated a high internal consistency of the test. The Pearson correlation (0.90) indicated high temporal stability. In terms of convergent validity, the ADI-12 showed moderate correlations with the Beck Anxiety Inventory (BAI) (0.51–0.58), and low correlations with time since ALS diagnosis (–0.26 to –0.27).
Limitations
The main limitation of the present study was the small sample size.
Conclusions
The ADI-12 is fitted to a single general factor of depression, and the scale shows high internal consistency and high temporal stability, therefore, its use is recommended for the diagnosis of depression in patients with ALS.
期刊介绍:
Archives of Medical Research serves as a platform for publishing original peer-reviewed medical research, aiming to bridge gaps created by medical specialization. The journal covers three main categories - biomedical, clinical, and epidemiological contributions, along with review articles and preliminary communications. With an international scope, it presents the study of diseases from diverse perspectives, offering the medical community original investigations ranging from molecular biology to clinical epidemiology in a single publication.